Technologies related to Therapeutic (small molecule)

MYC-G-Quadruplex Stabilizing Small Molecules and Their Use
Ref: E-053-2015/0 | Updated: Nov 22, 2017
Hypoxia Inducible Factor 1 (HIF-1) Inhibitors
Ref: E-115-2015/0 | Updated: Nov 20, 2017
Methods of Producing Effective T-cell Populations Using Akt Inhibitors
Ref: E-013-2016/0 | Updated: Nov 13, 2017
Near-IR Light-cleavable Conjugates and Conjugate Precursors
Ref: E-245-2016/0 | Updated: Oct 4, 2017
Methods of Making and Using Dopamine D3 Receptor Selective Antagonists/Partial Agonists
Ref: E-053-2016/0 | Updated: Mar 8, 2017
Triazole Derivatives of 4,7-disubstituted 2 naphthoic acid (PPTN) as P2Y14 Receptor Antagonists
Ref: E-213-2015/0 | Updated: Sep 6, 2016
Long Acting Therapeutic Conjugates with Evans Blue
Ref: E-143-2015/0 | Updated: Jun 27, 2016
Thalidomide Analogs that Inhibit Inflammation and Angiogenesis
Ref: E-208-2015/0 | Updated: Jan 4, 2016
TRPC Knockout (KO) Mice and Mice with a Floxed Allele of TRPC Ion Channel Genes
Ref: E-071-2014/2 | Updated: Dec 8, 2015
Mice with a Floxed Allele of the alpha Subunit of the Heterotrimeric G Protein Go or Gi2
Ref: E-071-2014/0 | Updated: Dec 8, 2015
Mouse Model for Study of Diabetic Nephropathy and Role of Soluble Epoxide Hydrolase
Ref: E-292-2015/0 | Updated: May 24, 2016
Prevention or Treatment of Viral Infections by Inhibition of the Histone Methyltransferases EZH1/2
Ref: E-141-2015/0 | Updated: Aug 10, 2015
Method of Treating Fumarate Hydratase-deficient Kidney Cancer
Ref: E-104-2014/0 | Updated: Sep 10, 2015
Novel Furoquinolinediones as Inhibitors of TDP2 and Their Potential Use to Treat Cancer
Ref: E-275-2014/0 | Updated: Nov 22, 2017
Novel Dopamine D2 Receptor Antagonists and Methods of Their Use
Ref: E-030-2013/0 | Updated: Sep 5, 2017
LRRK2 Inhibitors: Novel Treatment for Intestinal Bowel Disorders
Ref: E-070-2014/0 | Updated: Mar 22, 2016
Aza-Englerin Analogues - Novel Natural Product-Based Nitrogen-Containing Anti-Cancer Agents
Ref: E-090-2014/0 | Updated: Jan 13, 2015
Polyketal Nanoparticle Delivery of CpG Oligodeoxynucleotide for Treatment of Lung Cancer
Ref: E-159-2014/0 | Updated: Jan 13, 2015
Cannabinoid Receptor Meditating Compounds for Metabolic Disease
Ref: E-140-2014/0 | Updated: Aug 23, 2017
Chemotherapeutic Anti-cancer Agents
Ref: E-027-2014/0 | Updated: Oct 27, 2014
Use of Small Molecules to Treat PARP1-deficient Cancers
Ref: E-039-2014/0 | Updated: Dec 16, 2015
RNA Splicing Inhibitors to Treat Cancers
Ref: E-065-2014/0 | Updated: Jun 9, 2014
MDCK-based Reporter System for Detection of Influenza Viruses, Antiviral Drug Screening, and Analysis of Neutralizing Antibodies
Ref: E-185-2013/0 | Updated: May 15, 2014
Role of Novel Hepatitis Delta Virus Variant in Sjogren’s Syndrome
Ref: E-736-2013/0 | Updated: Apr 14, 2014
SCGB3A2 for Treatment of Cancer
Ref: E-286-2006/3 | Updated: Apr 15, 2014
Novel Small Molecule Antimalarials for Elimination of Malaria Transmission
Ref: E-751-2013/0 | Updated: Nov 18, 2015
Discovery of Novel PARP Inhibitors that Synergize with Topoisomerase I Inhibitors for Cancer Treatment
Ref: E-075-2014/0 | Updated: Mar 18, 2014
Human iPSC-Derived Mesodermal Precursor Cells and Differentiated Cells
Ref: E-342-2013/0 | Updated: Mar 18, 2014
Recombinant Sulfated HIV Envelope Protein and Methods for Making Protein
Ref: E-067-2012/0 | Updated: Apr 15, 2014
Methods for Amelioration and Treatment of Pathogen-associated Inflammatory Response
Ref: E-236-2013/0 | Updated: Feb 19, 2014
Therapeutic, Bifunctional Janus Microparticles with Spatially Segregated Surface Proteins and Methods of Production
Ref: E-457-2013/1 | Updated: Jan 28, 2014
Exposure and Activity Detection Assays for Anthrax Lethal Factor and Lethal Toxin
Ref: E-196-2013/0 | Updated: Mar 3, 2017
Methods of Treating or Preventing Pruritis (Itch)
Ref: E-485-2013/0 | Updated: Jan 16, 2014
Novel Epitopes of Bacillus anthracis Lethal Factor for Development of Diagnostics and Therapeutics
Ref: E-210-2013/0 | Updated: Mar 3, 2017
Intranasal Nebulizer with Disposable Drug Cartridge for Improved Delivery of Vaccines and Therapeutics
Ref: E-308-2013/0 | Updated: Apr 11, 2014
Intranasal Dry Powder Inhaler for Improved Delivery of Vaccines and Therapeutics
Ref: E-258-2013/0 | Updated: Dec 4, 2013
Photoactivatable Lipid-based Nanoparticles as a Vehicle for Dual Agent Delivery
Ref: E-482-2013/0 | Updated: Aug 16, 2017
Glucocerebrosidase Non-inhibitory Chaperones for the Treatment of Gaucher Disease, Parkinson's Disease, and Other Proteinopathies
Ref: E-144-2012/0 | Updated: Apr 16, 2014
Antagonists of Hyaluronan Signaling for Treatment of Airway Diseases
Ref: E-080-2012/0 | Updated: Oct 3, 2017
Lenalidomide Analogs for the Treatment of Neurodegenerative Disorders and Cancer
Ref: E-045-2012/0 | Updated: Dec 14, 2017
Coacervate Microparticles Useful for the Sustained Release Administration of Therapeutic Agents
Ref: E-116-2004/0 | Updated: Jun 29, 2017
Novel Methods for Reducing Inflammation and Treating Diseases such as Parkinson's and Alzheimer's Disease
Ref: E-130-2004/0 | Updated: Nov 4, 2015
Subscribe to Technologies related to Therapeutic (small molecule)